Loading, Please Wait...
CLEVELAND, Ohio, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and services, biotechnology, construction and building materials, today announces that the previously announced call center contract with a division of a Fortune 500 global healthcare solutions company, has expanded by an additional $600,000 annually. The initial contract award was announced on May 21, 2018. This is the third contract expansion for this client, has tripled initial contract billings, and will require Innovest to hire an additional ten employees in the next 45 days.
“This is exactly the type of organic growth that we continue to strive for, and a continues the great start to 2019. I have complete faith in our team and they continue to prove the power of the Innovest model to grow sales,” said Dan Martin, Innovest founder, Chairman and Chief Executive Officer. “Our president, Damon Mintz, is leading our team with targeted growth strategies to premier clients and on pursuit of new, larger acquisitions. In this case, Sally Emch and our call center team have once again stepped up and continue to support these efforts in a big way.”
About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, a Biotechnology Division, and a Construction & Building Materials Division.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.